Try our beta test site

Trial of Active Immunotherapy With Globo H-KLH (OPT-822) in Metastatic Breast Cancer Subjects

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
OBI Pharma, Inc
ClinicalTrials.gov Identifier:
NCT01516307
First received: January 19, 2012
Last updated: February 8, 2017
Last verified: February 2017
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: February 2017
  Primary Completion Date: August 2016 (Final data collection date for primary outcome measure)